Clinical Trials Browser

Phase 2 × Carcinoma, Merkel Cell × cabozantinib × Clear all

NCT02036476 2023-05-09

Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma

Phase 2 Terminated

8 enrolled 7 charts

Skin Neoplasms, Carcinoma, Merkel Cell